Unveiling the nephrotoxic profile of BCR‐ABL tyrosine kinase inhibitors: A real‐world experience in Africa

Abstract Introduction The efficacy of BCR‐ABL tyrosine kinase inhibitors (TKIs) in treating chronic myelogenous leukemia and other malignancies is well‐documented. However, concerns about potential nephrotoxicity have raised questions. This study, conducted at Tikur Anbesa Specialized Hospital (TASH...

Descrición completa

Detalles Bibliográficos

Principais autores:	Zekarias Seifu Ayalew, Gebeyehu Tessema Azibte, Fisihatsion Tadesse, Biruk Abate Legesse, Zerubabel Getahun Kiflu, Mahlet Tsige Weldeamanuel, Kibrekidusan Aynekulu Tsige, Bereket Abraha Molla, Addisu Melkie Ejigu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2024-08-01
Series:	eJHaem
Assuntos:	BCR‐ABL CML renal toxicities tyrosine kinase inhibitors
Acceso en liña:	https://doi.org/10.1002/jha2.988
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!